⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AAPG News
Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
globenewswire.com
AAPG
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
globenewswire.com
AAPG
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
globenewswire.com
AAPG
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
globenewswire.com
AAPG
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
globenewswire.com
AAPG
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
globenewswire.com
AAPG
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
globenewswire.com
AAPG
AAPL
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
globenewswire.com
AAPG
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
globenewswire.com
AAPG
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
globenewswire.com
AAPG